Simplex Trading
EVLO

Simplex Trading’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Simplex Trading’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed – – 10358
2023
Q2 		$0 Sell
8
-65
-89% -$193 ﹤0.01% 10350
2023
Q1 		$0 Buy
+73
New +$1.13K ﹤0.01% 10565
2022
Q2 		– Sell
-3,029
Closed -$140K – 11510
2022
Q1 		$205K Buy
3,029
+1,424
+89% +$119K ﹤0.01% 5121
2021
Q4 		$194K Buy
1,605
+1,601
+40,025% +$270K ﹤0.01% 5245
2021
Q3 		$1K Hold
4
– – ﹤0.01% 9708
2021
Q2 		$1K Sell
4
-7
-64% -$1.77K ﹤0.01% 9886
2021
Q1 		$2K Buy
+11
New +$3.04K ﹤0.01% 8509

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Simplex Trading's EVLO Position: Q3 2023 in Review

Simplex Trading sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2023, closing a stake of 8 shares.

Simplex Trading first reported a position in EVLO in Q1 2021 and held it in 7 quarters. The position peaked at $205K in Q1 2022. 29 funds tracked by Wall St. Rank hold EVLO as of Q3 2023.

  • Simplex Trading reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 8 Evelo Biosciences, Inc. Common Stock shares in Q3 2023.
  • Simplex Trading first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Simplex Trading's Evelo Biosciences, Inc. Common Stock position peaked at $205K in Q1 2022.
  • 29 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.